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Abstract 
 
Olfactory ensheathing cells (OECs) play an important role in the continuous regeneration of the 
primary olfactory nervous system throughout life and for regeneration of olfactory neurons after 
injury. While it is known that several individual OEC subpopulations with distinct properties exist 
in different anatomical locations, it remains unclear how these different subpopulations respond to a 
major injury. We have examined the proliferation of OECs from one distinct location, the peripheral 
accessory olfactory nervous system, following large-scale injury (bulbectomy) in mice. We used 
crosses of two transgenic reporter mouse lines, S100ß-DsRed and OMP-ZsGreen, to visualise 
OECs, and main/accessory olfactory neurons, respectively. We surgically removed one olfactory 
bulb including the accessory olfactory bulb to induce degeneration, and found that accessory OECs 
in the nerve bundles that terminate in the accessory olfactory bulb responded by increased 
proliferation with a peak occurring 2 days after the injury. To label proliferating cells we used the 
thymidine analogue ethynyl deoxyuridine (EdU) using intranasal delivery instead of intraperitoneal 
injection. We compared and quantified the number of proliferating cells at different regions at one 
and four days after EdU labelling by the two different methods and found that intranasal delivery 
method was as effective as intraperitoneal injection. We demonstrated that accessory OECs actively 
respond to widespread degeneration of accessory olfactory axons by proliferating. These results 
have important implications for selecting the source of OECs for neural regeneration therapies and 
show that intranasal delivery of EdU is an efficient and reliable method for assessing proliferation 
of olfactory glia.  
	
 
 
 
 
Keywords: accessory olfactory bulb; glia; vomeronasal; regeneration; axon  
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Introduction 
 
 
Olfactory ensheathing cells (OECs) are the glial cells of the olfactory nervous system that ensheathe 
fascicles of main and accessory olfactory axons. OECs exhibit unique growth-promoting and 
migratory properties amongst glia and are now regarded as essential for the turnover of olfactory 
neurons and for regeneration after injury [1].  
 
OECs express a variety of neurotrophic factors [2-3] which are important for the extension and 
guidance of axons and have led to the investigation of OECs for neural regeneration therapies. We 
have previously shown that following unilateral bulbectomy, there is a massive influx of OECs 
from the main olfactory system into the cavity left by the removal of the olfactory bulb [4-5]. The 
OECs proliferate and migrate in different regions of the olfactory nerve towards the cavity in 
response to widespread degeneration of the entire olfactory nerve pathway.  
 
While it is clear that OECs in the main olfactory nervous system in rodents proliferate in response 
to widespread degeneration of olfactory axons, little is known about how OECs in the accessory 
olfactory nervous system, which is responsible for detecting pheromones, respond to neuronal 
injury. The cell bodies of accessory olfactory neurons reside in a distinct region of the olfactory 
epithelium, the vomeronasal organ. Their axons extend into the accessory olfactory bulb in the 
brain, localised caudally to the main olfactory bulb.  We have previously shown that accessory 
olfactory neurons degenerate in response to unilateral bulbectomy as the accessory olfactory bulb is 
also removed by the procedure [6]. We therefore hypothesised that OECs ensheathing accessory 
olfactory neurons respond to widespread neuronal degeneration and investigated the response 
following bulbectomy. 
 
To label proliferating cells, we have used a novel method of delivery of 5-ethynyl-2’-deoxyuridine 
(EdU). Currently, the method of application is intraperitoneal injection of EdU which can be 
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difficult in neonatal mice due to lack of skin elasticity and hence there can often be a leakage of the 
injected fluid. We have now developed an intranasal delivery method and found that EdU is 
incorporated into dividing cells following intranasal application as effectively as after 
intraperitoneal injection. 	
 
Overall, our results showed that the OECs of the peripheral accessory olfactory nervous system 
proliferate in response to large-scale neuronal injury, similar to the OECs of the main olfactory 
nervous system. These findings have increased our understanding of how different subpopulations 
of OECs respond to injury, which is highly warranted for future developments of new nerve repair 
therapies.  
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Materials and methods     
 
Animals 
We used postnatal pups of crosses of two transgenic reporter lines of mice, OMP-ZsGreen [7-8] and 
S100ß-DsRed [9]. All procedures were carried out with the approval of the Griffith University 
Animal Ethics Committee.  
 
EdU delivery 
The animals received EdU (5-ethyl-2’-deoxyuridine, Invitrogen) at a dose of 50 mg/kg body weight 
in 20 mg/ml in PBS. For comparison of intranasal versus intraperitoneal injection, the same dose 
was applied for the two different delivery methods. For intranasal delivery, the pups received 8 μL 
to each nostril. Intraperitoneal delivery was injected as previously described [10] with 16 μL 
injected.  For acute EdU labelling, postnatal day 4 pups received either intranasal or intraperitoneal 
EdU, and euthanased at P5 to harvest tissues. For long term EdU labelling, pups received intranasal 
or intraperitoneal EdU at P4 and then harvested at P8. Three animals were used for each treatment 
at each timepoint. 
 
EdU administration to quantify OEC proliferation 
Animals that had undergone bulbectomy treatment.were given EdU intranasally at 2, 4, 7 or 9 days 
after treatment and sacrificed 4 h later. The EdU Click-iT reaction (Invitrogen) was performed as 
previously described [10].  
 
Surgical ablation of olfactory bulb (unilateral bulbectomy)  
The olfactory bulb was removed unilaterally at postnatal day (P) 4.5 as described previously [6]. 
For each time point littermates were used with three unoperated control pups and three pups that 
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underwent surgery. Mice were killed by cervical dislocation and the heads were fixed in 
paraformaldehyde, frozen and sections cut (30 m) on a cryostat. 
 
Image capture and image preparation  
Images were captured using an Axio Imager Z1 epi-fluorescence microscope or an Olympus 
FV1000 microscope.  
 
Quantification of OECs  
For each time point, three animals with at least three sections per animal were examined, with the 
total number of cells counted being at least 30-90 for each data point. Regions of interest (200 x 150 
m2) from the ventral nasal septum below the main olfactory epithelium where accessory olfactory 
axons bundle are present were selected as indicated in Fig. 3C. The total numbers of OECs and 
EdU-labelled OECs were counted. The percentage of EdU-labelled cells was calculated in each 
region using equal surface areas. Statistical significance was assessed using ANOVA and Tukey’s 
post hoc test.  
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Results  
        
Intranasal delivery of EdU labels proliferating cells in different tissues  
After intranasal delivery of EdU into P4 pups, numerous EdU-labelled cells could be visualised in 
the nasal cavity and the labelling pattern was similar to that seen with intraperitoneal injection of 
EdU (Fig. 1A-B). Cells in the olfactory epithelium were labelled (Fig. 1A, C) as well as other cell 
types throughout the nasal cavity and olfactory bulb (Fig. 1A). EdU-labelled cells that had 
proliferated in the cartilage of the nasal septum (Fig. 1D) and skeletal muscle attached to the skull 
were detected (Fig. 1E). Throughout all tissues examined, EdU co-localised with cell nuclei (DAPI 
labelling). The extensive labelling of cells that had proliferated in the olfactory epithelium 
demonstrates effective penetration of EdU by the intranasal delivery method (Fig. 1A). In the 
olfactory epithelium, cells located in the basal and apical layers of epithelium were labelled with 
EdU, including sustentacular (arrowhead, Fig. 1C) and horizontal basal cells (arrow with tail, Fig. 
1C). Other EdU-labelled cells were also distributed throughout the lamina propria underneath the 
olfactory epithelium (Fig. 1C). At four days after intranasal delivery of EdU, numerous cells were 
labelled in the olfactory bulb, rostral migratory stream (RMS), and epidermis (Fig. 1F-H). In the 
olfactory bulb, EdU-labelled cells were present in the nerve fibre layer, where OECs are localised 
(Fig. 1F). These results showed that the EdU-positive cells retained the labelling after several days 
similar to what we observe using the intraperitoneal injection method. 
 
Quantification of EdU positive cells  
To determine the efficiency of intranasal delivery of EdU in comparison to intraperitoneal injection, 
we quantified the number of EdU-labelled cells, in different tissues. The quantification showed that 
there were no significant differences in the number of proliferating cells in the two methods in 
different tissues (Fig. 2A-B, ANOVA and post hoc t test, p>0.05 for individual comparisons), 
indicating the efficiency of intranasal delivery of EdU similar to the standard method of delivery.  
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Removal of the olfactory bulb induced proliferation of accessory OECs  
To determine whether proliferation of OECs from the accessory olfactory system is stimulated by a 
major injury, we performed unilateral bulbectomy in postnatal mice. Unilateral ablation of an 
olfactory bulb which includes removal of the accessory olfactory bulb (bulbectomy) results in 
widespread death of olfactory neurons as well as obliteration of almost all central OECs; however, 
the contralateral olfactory bulb is relatively unaffected. Postnatal animals were chosen in preference 
to adults as their regeneration of olfactory neurons is more rapid and uniform [5]. In unilaterally 
bulbectomised mice, the resulting damage of the sensory axons led to degeneration of the neurons 
in the ipsilateral olfactory epithelium and vomeronasal organ which became thinner and had fewer 
ZsGreen-positive accessory olfactory neurons (left vomeronasal epithelium, Fig. 3B, D) compared 
to the contralateral control side (right vomeronasal epithelium, Fig. 3B, F). Subsequently, the 
accessory olfactory axons degenerated completely on the bulbectomy side (Fig. 3E) whereas the 
accessory olfactory axons on the contralateral control side maintained their uniform distribution 
throughout the accessory olfactory nerve bundles (Fig. 3G).  
 
To determine whether accessory OECs proliferated in response to the bulbectomy, proliferating 
cells were labelled by intranasally delivered EdU at days 2-9 after bulbectomy and harvested 4 h 
later. OECs that underwent proliferation at other times would remain unlabelled. In S100ß-DsRed 
transgenic mice, accessory OECs are easily identified by their expression of DsRed, their 
morphology and their association with accessory olfactory axons (see Fig. 3E, G). Based on these 
characteristics, accessory OECs in the regions indicated in Fig. 3C (arrows) were clearly labelled by 
EdU. As expected, not all OECs were proliferating at the time of EdU exposure and thus EdU-
negative OECs were also observed (Fig. 4; arrows with tailin Fig. 4A, D, G). To quantify the 
proportion of OECs that had proliferated, we examined only the accessory OECs in the nerve 
bundles that were clearly separated from the main olfactory region (see arrows in Fig. 3C). After 
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bulbectomy, numerous EdU-positive OECs were present in these accessory olfactory nerve bundles 
at all periods examined. On the contralateral control side, there were fewer OECs labelled with EdU 
(Fig. 4D-F), and in unoperated control animals even fewer EdU-labelled OECs were seen (Figure 
4G-I).  
 
Quantification of the number of EdU-positive cells in the different conditions showed that at days 
2-9 after bulbectomy, significantly more proliferating accessory OECs were detected in the 
ipsilateral nasal epithelium compared to contralateral control and unoperated controls (p<0.01 at 2-4 
days, p<0.05 at 7-9 days, Fig. 4J). The peak of proliferation occurred at day 2 after surgery with 
EdU-labelled OECs comprising 11% of the total population of accessory OECs. Accessory OECs 
also proliferated in the lamina propria contralateral to the bulbectomy with 6-7% of OECs being 
EdU-positive (Fig.4J). This percentage was significantly higher than in unoperated animals 
(control; 3% at day 2, Fig. 4J), suggesting that the contralateral olfactory nervous system is also 
affected by bulbectomy. By day 9 after bulbectomy, the number of proliferating accessory OECs in 
the bulbectomised side was still significantly higher than the contralateral control and unoperated 
controls although it was reduced towards normal proliferation rate (~2% as seen in unoperated 
control animals).  
 
These findings demonstrate that accessory OECs respond to large-scale injury to the central part of 
the olfactory nervous system by increased proliferation, with particularly high levels of proliferation 
occurring for 2-7 days after bulbectomy. 
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Discussion  
   
EdU is an alternative thymidine analogue for labeling proliferating cells and is commonly delivered 
by intraperitoneal injection [11-14]. Here, we report a new method of delivery of EdU to label 
proliferating cells in the olfactory nervous system and associated tissue. Our results confirmed that 
intranasal delivery of EdU labelled the same proportion of cells that had proliferated as the standard 
intraperitoneal injection method and cells were labelled by EdU not only in the nasal cavity but in 
surrounding skin, muscle, and cartilage. These results illustrate that intranasal delivery of EdU can 
be used for acute and long term labelling of proliferating cells.  
 
The surgical removal of one olfactory bulb including the accessory olfactory bulb rapidly resulted 
in the loss of neurons from the vomeronasal organ as well as loss of axons within the accessory 
olfactory nerve bundles on side from which the bulb was removed. To ensure accurate identification 
of the accessory olfactory nerve bundles we examined only those axon bundles that were located 
ventral to the main olfactory epithelium. The found that the accessory OECs rapidly responded to 
the ablation of the accessory olfactory bulb by undergoing proliferation with the peak of 
proliferation occurring two days after bulbectomy, when 11 % of accessory OECs underwent 
proliferation. This percentage is similar to that we have previously reported for OECs from the main 
olfactory nervous system (10 %) [4]. Other studies which have examined the proliferation of OECs 
have reported low levels or negligible levels of proliferation after destruction of the olfactory 
epithelium [15] or in nerve transection models in adult rats [16]. The differences are likely to reflect 
in part that we have used young postnatal animals whereas other studies have used adult animals, 
but nevertheless it is clear from our study that OECs are able to detect the sudden loss of axons and 
to respond by rapid proliferation. 
 
Our results also indicate that there are differences between the accessory and main olfactory OECs 
in the time at which proliferation reaches its peak. We have previously reported that for main 
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olfactory system, OECs within nerve bundles in the lamina propria, the peak of proliferation 
occurred at day 5 after bulbectomy [4], whereas in the current study the peak of proliferation of the 
accessory OECs occurred two days after surgery. These differences are potentially of importance 
for the purification of OECs for neural transplant therapies. Main olfactory OECs are often purified 
from the lamina propria lining the septum [17-18]; however in the more caudal regions of the nasal 
cavity the accessory olfactory nerve bundles also project along the dorsal septum and they lie 
basally to the main olfactory nerve bundles. Thus, purification of OECs from the dorsal septal 
region may therefore include OECs from the main as well as the accessory olfactory nerve bundles. 
If the accessory OECs respond and proliferate earlier than the main OECs then the proportion of 
accessory OECs could be higher than previously considered. As we have shown that OECs from 
different regions have different cell-cell interaction properties [19], it is essential for cell transplant 
therapies that the composition and overall properties of purified cells is comprehensively 
determined to ensure reproducibility of experimental outcomes. 
 
In summary, we have shown that intranasal delivery of EdU is an efficient method for labelling 
proliferating cells in young postnatal pups. We have used this method to determine that accessory 
OECs rapidly respond to unilateral bulbectomy of the accessory olfactory bulb and that they 
proliferate in the accessory nerve bundles that project out of the vomeronasal organ.   
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Figure legends 
 
Figure 1. Proliferating cells were detected throughout the olfactory and nasal tissue after intranasal 
delivery of EdU. Panels are coronal sections through the nasal cavity and rostral brain. (A) One day 
after intranasal delivery of EdU, cells that had proliferated throughout the nasal cavity were 
labelled. (B) One day after intraperitoneal EdU, the distribution of EdU-positive cells was similar to 
the intranasal delivery method. (C-E) Higher magnification of different tissues, including olfactory 
mucosa (C), cartilage within the nasal septum (D) and skeletal muscle (E). (C) Within the olfactory 
mucosa, cells lining the basal layer of the olfactory epithelium (OE) (arrow) and within the lamina 
propria (LP) (arrow with tail) were labelled; and sustentacular cells in the apical epithelium were 
also labelled (arrowhead). (F-H) Four days post intranasal delivery, EdU-positive cells (magenta, 
arrows) were present in the olfactory bulb (OB) (F), an extension of rostral migratory stream (RMS) 
(G) and the basal cells of the epidermis (H). GL, glomerular layer; OM, olfactory mucosa; NFL, 
nerve fibre layer; S, septum. Scale bar: 500 μm in A-B and 35 in μm (C-H). 
 
Figure 2. Acute and long-term labelling of proliferating cells by intranasal and intraperitoneal 
delivery of EdU. Quantification of the number of EdU-positive cells which were labelled by 
intranasal (black columns) or intraperitoneal (grey columns) delivery in the olfactory epithelium 
(OE), olfactory bulb (OB), skeletal muscle (SM), cartilage (CT) and respiratory epithelium (RE). 
One and four days after labelling, similar numbers of proliferating cells were labelled by the two 
methods (A-B). There was no significant difference between the number of EdU-positive cells at 
either 1 or 4 days labelling, p>0.05; ANOVA; error bars represent the standard error of the mean.  
 
Figure 3. Accessory OECs proliferate after unilateral bulbectomy. Panels are coronal sections 
through the main olfactory and vomeronasal (VNO) regions of postnatal OMP-ZsGreen x S100ß-
DsRed mice that had undergone unilateral bulbectomy and then labelled with EdU 4 h prior to 
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harvest. Primary olfactory neurons and accessory olfactory neurons are green; OECs are red; nuclei 
are stained with DAPI (blue). (A) Seven days after bulbectomy, the regenerating olfactory axons 
(arrow) penetrated the ventral region of the cavity left after bulbectomy; the contralateral olfactory 
bulb (OB) is intact. (B) The rostral nasal cavity two days after bulbectomy showing the main 
olfactory epithelium (MOE) and the vomeronasal organ (VNO), boxed areas are shown in D and F. 
(C) The ventral septum showing the vomeronasal nerve bundles (arrows) which are distinctly 
separated from the MOE. Boxed areas are shown in E and G. (D) Neurons (green) within the 
vomeronasal epithelium on the bulbectomy side were degenerated. (E) Within the vomeronasal 
nerve bundles on the bulbectomy side, the accessory olfactory axons (arrow) were degenerated. (F-
G) On the contralateral side, the neurons within the vomeronasal epithelium were healthy (F) and 
the axons within the vomeronasal nerve bundles were intact (arrow in G). S, septum. Scale bar is 
800 μm in A; 600 μm in B; 220 μm in C; 40 μm in D, F; 20 μm in E, G. 
 
Figure 4. Accessory OECs in the lamina propria proliferated after bulbectomy. (A-I) Panels are 
coronal sections through the nasal septum in the region ventral to the main olfactory epithelium of 
unilaterally bulbectomised mice, 2 days after surgery and 4 h after intranasal EdU delivery. Images 
show OECs (red), and EdU (yellow); merged images are in A, D G. Numerous OECs (red) within 
the accessory olfactory axons bundles were co-labelled with EdU (yellow, arrows) on the operated 
side (A-C); not all OECs were labelled by EdU (arrow with tail). Fewer OECs were co-labelled 
with EdU on the contralateral control side (D-F) and in unoperated control animals (G-I); not all 
OECs were labelled by EdU (arrow with tail). (J) Quantification of the percentage of OECs that 
were labelled by EdU on the ipsilateral operated side, the contralateral control side and in 
unoperated control animals. There was a significant difference between the operated side and both 
the contralateral control side and unoperated controls at all time points; ** p<0.01; Tukey HSD for 
2-4 days and * p<0.05 for 7-10 days; significant difference was present between the contralateral 
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control side and unoperated control only at 2 days after bulbectomy, * p<0.05; error bars are 
standard error of the mean. Scale bar is 50 µm. 
 
